ACE Inhibitor/Angiotensin Receptor Blocker Use Patterns in Advanced CKD and Risk of Kidney Failure and Death

RATIONALE & OBJECTIVE: The use of renin-angiotensin system (RAS) inhibitors is standard of care in people with early to moderate chronic kidney disease (CKD). Less is known regarding the efficacy of RAS inhibitors in very advanced CKD. In this study, we describe patterns of use of RAS inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Nayan, Katz, Ronit, Bansal, Nisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380396/
https://www.ncbi.nlm.nih.gov/pubmed/32734244
http://dx.doi.org/10.1016/j.xkme.2019.12.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380396/
https://www.ncbi.nlm.nih.gov/pubmed/32734244
http://dx.doi.org/10.1016/j.xkme.2019.12.007

Ejemplares similares